Related references
Note: Only part of the references are listed.Multifunctional T cell response in active pulmonary tuberculosis patients
Shuang Qin et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Antigen-Specific IFN-γ/IL-17-Co-Producing CD4+ T-Cells are the Determinants for Protective Efficacy of Tuberculosis Subunit Vaccine
Han-Gyu Choi et al.
VACCINES (2020)
Constitutive STAT3 phosphorylation and IL-6/IL-10 co-expression are associated with impaired T-cell function in tuberculosis patients
Kirstin Harling et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
Type I interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytes
Chunwan Lu et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Dual inhibition of STAT1 and STAT3 activation downregulates expression of PD-L1 in human breast cancer cells
Varun Sasidharan Nair et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2018)
1The exhausted CD4+CXCR5+ T cells involve the pathogenesis of human tuberculosis disease
Munyemana Jean Bosco et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2018)
Memory of Natural Killer Cells: A New Chance against Mycobacterium tuberculosis?
Jose Alberto Choreno Parra et al.
FRONTIERS IN IMMUNOLOGY (2017)
STAT3 signaling in immunity
Emily J. Hillmer et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2016)
TIM3 Mediates T Cell Exhaustion during Mycobacterium tuberculosis Infection
Pushpa Jayaraman et al.
PLOS PATHOGENS (2016)
PD-1/PD-L pathway inhibits M.tb-specific CD4+ T-cell functions and phagocytosis of macrophages in active tuberculosis
Lei Shen et al.
SCIENTIFIC REPORTS (2016)
Latent Mycobacterium tuberculosis Infection
Haileyesus Getahun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Constitutive STAT3 Phosphorylation in Circulating CD4+ T Lymphocytes Associates with Disease Activity and Treatment Response in Recent-Onset Rheumatoid Arthritis
Krista Kuuliala et al.
PLOS ONE (2015)
The activity of JAK-STAT pathways in rheumatoid arthritis: constitutive activation of STAT3 correlates with interleukin 6 levels
Pia Isomaki et al.
RHEUMATOLOGY (2015)
Multiple regulation pathways and pivotal biological functions of STAT3 in cancer
Jie Yuan et al.
SCIENTIFIC REPORTS (2015)
Phosphorylated STAT3 and PD-1 regulate IL-17 production and IL-23 receptor expression in Mycobacterium tuberculosis infection
Anuradha Bandaru et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Alteration of serum inflammatory cytokines in active pulmonary tuberculosis following anti-tuberculosis drug therapy
Imran Hussain Chowdhury et al.
MOLECULAR IMMUNOLOGY (2014)
SOCS3 and STAT3, major controllers of the outcome of infection with Mycobacterium tuberculosis
Martin E. Rottenberg et al.
SEMINARS IN IMMUNOLOGY (2014)
Functional signatures of human CD4 and CD8T cell responses to Mycobacterium tuberculosis
Teresa Prezzemolo et al.
FRONTIERS IN IMMUNOLOGY (2014)
Expression of M. tuberculosis-induced suppressor of cytokine signaling (SOCS) 1, SOCS3, FoxP3 and secretion of IL-6 associates with differing clinical severity of tuberculosis
Kiran I. Masood et al.
BMC INFECTIOUS DISEASES (2013)
Inhibiting the Programmed Death 1 Pathway Rescues Mycobacterium tuberculosis-Specific Interferon γ-Producing T Cells From Apoptosis in Patients With Pulmonary Tuberculosis
Amar Singh et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Shedding Light on Apoptosis at Subcellular Membranes
Justin Kale et al.
CELL (2012)
Reduced Th17 Response in Patients with Tuberculosis Correlates with IL-6R Expression on CD4+ T Cells
Xinchun Chen et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
PD-1-PD-L1 pathway impairs Th1 immune response in the late stage of infection with Mycobacterium bovis bacillus Calmette-Guerin
Shunsuke Sakai et al.
INTERNATIONAL IMMUNOLOGY (2010)
Essential Role of IL-17A in the Formation of a Mycobacterial Infection-Induced Granuloma in the Lung
Yuko Okamoto Yoshida et al.
JOURNAL OF IMMUNOLOGY (2010)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis
Javier O. Jurado et al.
JOURNAL OF IMMUNOLOGY (2008)
T-cell quality in memory and protection: implications for vaccine design
Robert A. Seder et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover
Jorge R. Almeida et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
Patricia A. Darrah et al.
NATURE MEDICINE (2007)
IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge
Shabaana A. Khader et al.
NATURE IMMUNOLOGY (2007)
Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NF kappa B
Jinbo Yang et al.
GENES & DEVELOPMENT (2007)
Tumor necrosis factor is critical to control tuberculosis infection
Muazzam Jacobs et al.
MICROBES AND INFECTION (2007)
The history of tuberculosis
Thomas M. Daniel
RESPIRATORY MEDICINE (2006)
On the nature of Mycobacterium tuberculosis-latent bacilli
PJ Cardona et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
Alternative activation of STAT1 and STAT3 in response to interferon-γ
YL Qing et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Constitutive STAT3 activation in intestinal T cells from patients with Crohn's disease
P Lovato et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent
J Keane et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
